| Current Price | $139.99 | Mkt Cap | $369.8B |
|---|---|---|---|
| Open | $140.80 | P/E Ratio | 26.38 |
| Prev. Close | $140.50 | Div. (Yield) | $3.75 (2.7%) |
| Daily Range | $139.91 - $140.97 | Volume | 1,674,766 |
| 52-Wk Range | $125.00 - $144.98 | Avg. Daily Vol. | 7,507,724 |
A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.
| Current Price | $139.99 | Mkt Cap | $369.8B |
|---|---|---|---|
| Open | $140.80 | P/E Ratio | 26.38 |
| Prev. Close | $140.50 | Div. (Yield) | $3.75 (2.7%) |
| Daily Range | $139.91 - $140.97 | Volume | 1,674,766 |
| 52-Wk Range | $125.00 - $144.98 | Avg. Daily Vol. | 7,507,724 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about JNJ.
Recs
nolledge
(52.00)
Submitted: 10/10/2019 12:36:37 AM :
Start Price:
$130.10
NYSE:JNJ Score:
-0.21
Rationale: Johnson & Johnson has a lot of risk from various law suits, and they tend to compound (bad evidence from one increases risk from another). I also think the device/pharma industries have had a great couple decades and broadly have risk of underperforming if they lose their ability to pass on exorbitant product prices to a price-insenstive 3rd party payer.
Risk: they trade at a reasonable market value, so they just have to continue to perform to beat my expectation. But I just need them to take bigger hits than expected, relative to the market.
Recs
TMFCheesehead
(94.74)
Submitted: 5/20/2019 10:28:55 AM :
Start Price:
$135.84
NYSE:JNJ Score:
-6.67
Don't think it'll be a market-thumper, but a solid choice
Recs
CellBlock9
(90.56)
Submitted: 12/18/2018 9:14:44 PM :
Start Price:
$126.32
NYSE:JNJ Score:
-11.76
spyg
Find the members with the highest scoring picks in JNJ.
PassDaRice2 (77.41) Score: +133.07
The Score Leader is the player with the highest score across all their picks in JNJ.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| tarfu773 | 88.60 | 7/30/2007 |
|
5Y | $41.31 | +239.66% | +123.59% | +116.07 | 1 Comment | |
| UWxBadger | 93.95 | 7/30/2007 |
|
5Y | $41.33 | +239.48% | +123.42% | +116.06 | 0 Comment | |
| diediedieno | 40.60 | 7/27/2007 |
|
5Y | $41.33 | +239.43% | +123.37% | +116.06 | 0 Comment | |
| bullear1 | 63.72 | 7/24/2007 |
|
3Y | $42.32 | +231.49% | +115.46% | +116.03 | 0 Comment | |
| jbarnes1217 | 94.11 | 7/24/2007 |
|
3Y | $42.32 | +231.49% | +115.46% | +116.03 | 0 Comment | |
| paladin65 | < 20 | 7/24/2007 |
|
1Y | $42.32 | +231.49% | +115.46% | +116.03 | 1 Comment | |
| cando123 | 24.04 | 7/24/2007 |
|
5Y | $42.32 | +231.49% | +115.46% | +116.03 | 0 Comment | |
| GreedyMo | 94.17 |
|
|
5Y | $42.32 | +231.49% | +115.46% | +116.03 | 0 Comment | |
| fartalope | < 20 | 7/24/2007 |
|
5Y | $42.32 | +231.49% | +115.46% | +116.03 | 1 Comment | |
| kaibigan | 20.43 | 7/24/2007 |
|
NS | $42.32 | +231.49% | +115.46% | +116.03 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
